CENTOGENE News & Events Header Image Broschure


Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

Digitalisierung - was braucht das Land und was braucht die Wirtschaft am Beispiel einer Erfolgsgeschichte der Branche Gesundheitswirtschaft

One of the largest, most ethnically diverse studies of Parkinson’s disease to uncover the genetic basis of one of the most common neurodegenerative…

CENTOGENE today announced the expansion of its executive leadership team with the appointment of Sun Kim in Boston, MA as Chief Strategy & Investor…

Thank you to everyone who joined us during Rostock’s Night of Sciences at our HQ. It was a pleasure for us to welcome so many of our neighbors to…

Research Fellow from German Research Center for Artificial Intelligence to lead team driving solutions for pharmaceutical partners.

Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions.

CENTOGENE announced today that Dr. Flemming Ornskov has been appointed to the Supervisory Board and has been elected Non-Executive Chairman. His…

As part of an exchange with senior business and academic leaders, and state of Mecklenburg-Vorpommern (M-V) government representatives, a discussion…

Agreement focused on identification of patients with Duchenne muscular dystrophy (DMD)

CENTOGENE, a rare disease company committed to improving the lives of rare disease patients by providing solutions that accelerate the development of…

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us


Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.